Respiratory

LP-300 Phase 2 Results Expected

LP-300 • Adenocarcinoma of Lung

Lorundrostat Phase 2 Results Expected

Lorundrostat • Obstructive Sleep Apnea

lorundrostat Phase 3 Results Expected

Lorundrostat • Obstructive Sleep Apnea

TNG260 Phase 2 Results Expected

TNG260 • Non Small Cell Lung Cancer

CLN-081 Phase 2 Results Expected

CLN-081 • Non Small Cell Lung Cancer

Treprostinil Palmitil Inhalation Powder Phase 3 Results Expected

Treprostinil Palmitil Inhalation Powder • Pulmonary Hypertension

MCLA-129 Phase 2 Results Expected

MCLA-129 • Non-Small Cell Lung Cancer Metastatic

Ruxolitinib Phase 3 Results Expected

Ruxolitinib • Myelofibrosis

efzofitimod 450 mg Phase 2 Results Expected

efzofitimod 450 mg • Interstitial Lung Disease

Selinexor 60 mg Phase 2 Results Expected

Selinexor 60 mg • Myelofibrosis